Tag: Antipsychotic injections

The Food and Drug Administration (FDA) has not approved a 3-week dosing interval for any formulation of Invega, including Invega Sustenna or Invega Trinza. The specific release mechanisms of these long-acting injectable antipsychotics are engineered for longer durations, making the question, **can Invega be given every 3 weeks**, a critical safety and efficacy concern for patients and clinicians.

Antipsychotic injections, also known as long-acting injectables (LAIs), are designed to release medication slowly and can last anywhere from two weeks to six months. For individuals with schizophrenia, understanding **how long does a schizophrenia injection last?** is a critical factor in managing their treatment and improving adherence.

The economic burden of schizophrenia is significant, with total direct costs potentially reaching billions annually in the U.S.. Understanding **how much does the schizophrenia injection cost** is crucial, as prices can vary drastically depending on the specific medication, dosage, and insurance plan. These long-acting injectables, while initially expensive, often reduce long-term costs associated with hospital stays.